slide1 n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Duke University, Durham, NC PowerPoint Presentation
Download Presentation
Duke University, Durham, NC

Loading in 2 Seconds...

play fullscreen
1 / 1

Duke University, Durham, NC - PowerPoint PPT Presentation


  • 53 Views
  • Uploaded on

Association Between Platelet Aggregation and Mental Stress Induced Myocardial Ischemia: Results From the REMIT Trial.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Duke University, Durham, NC' - latona


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide1

Association Between Platelet Aggregation and Mental Stress Induced Myocardial Ischemia: Results From the REMIT Trial

Robert W. Harrison, MD; Richard C. Becker, MD; Thomas L. Ortel, MD, PhD; Maragatha Kuchibhatla, PhD; Stephen H. Boyle, PhD; Zainab Samad, MD; Eric J. Velazquez, MD; Jennifer Wilson, BA; Cynthia Kuhn, PhD; Redford B. Williams, MD; Christopher M. O’Connor, MD; Wei Jiang, MD

Duke University, Durham, NC

Results

Background

Disclosures:

Harrison, RW: None

Becker, RC: Honoraria; Bristol-Myers Squibb, Sanofi-Aventis, Boehringer Ingelheim. Research Grants; Bristol-Myers Squibb, Bayer Pharmaceuticals, Johns and Johnson, Regado Biosciences, and AstraZeneca

Ortel, JL: Honoraria; Boehringer Ingelheim, Instrumentation Laboratories. Research Grants; Pfizer, Eisai, and GSK

Kuchibhatla, M: None

Boyle, SH: None

Samad, Z: None

Velazquez, EJ: Honoraria; Novartis. Speaker’s Bureau; Gilead. Research Grants; Abbott-Vascular

Wilson, J: None

Kuhn, C: None

Williams, RB: Ownership/Partnership/Principal; Williams LifeSkills, Inc.

O’Connor, CM: Honoraria; Novella, Cardiology Consulting Associates, Amgen. Ownership/Partnership/ Principal; BiscardiaLLC. Research Grants; Otsuka, Roche Diagnostics, BG Medicine, Critical Diagnostics, Astellas, Gilead, GE Healthcare, ResMed

Jiang, W: None

Sponsorship:

National Heart, Lung, and Blood Institute grant number RHL085704

Table 2: Baseline resting platelet aggregation

Table 1: Baseline characteristics

  • Patients with coronary heart disease are susceptible to mental stress-induced myocardial ischemia (MSIMI),and patients susceptible to MSIMI have a poorer prognosis1
  • MSIMI was more common than exercise induced myocardial ischemia in the REMIT trial, affecting 43% of patients with coronary heart disease2
  • Patients with MSIMI have a poorer prognosis than those who do not exhibit MSIMI1
  • Platelet activation is an important factor in acute coronary syndromes, and patients with depression and hostility have increased platelet reactivity. However, an association between platelet reactivity and MSIMI has not been established1

Objectives

  • Assess platelet aggregation before and after mental stress testing in patients with known coronary heart disease
  • Hypothesis: Patients who are susceptible to MSIMI will have increased mental stress induced platelet aggregation compared to those without MSIMI

Methods

  • REMIT
  • NHLBI sponsored randomized clinical trial designed to assess the efficacy of escitalopram on MSIMI in patients with established coronary artery disease
  • Eligible patients: Adults with clinically stable coronary heart disease (prior stenosis > 70%, or history of myocardial infarction or revascularization)
  • Study Procedure
  • Subjects were administered a series of 3 mental tasks: 1) mental arithmetic, 2) public speaking with anger recall, and 3) mirror tracing
  • Blood samples were collected before and after mental stress testing to assess platelet aggregation
  • Platelet Aggregation
  • Aggregation determined with a BIO-DATA 4-channel platelet aggregometer. Variables of interest included the area under the platelet aggregation curve (AUC) and the maximal amplitude of platelet aggregation (%)
  • Aggregation triggered by epinephrine (1, 2, 5, an 10 µM), collagen (1, 2, 5, and 10 µM), adenosine diphosphate (ADP; 1, 2, µM), and each agonist with serotonin (5HT; 10 µM)
  • Endpoints:
  • MSIMI: a decrease in EF of ≥ 8% or a new focal wall motion abnormality induced by mental stress testing
  • Normal left ventricular response (NLVR): No change or an increase in EF, and no focal wall motion abnormalities in response to mental stress testing

Figure: Adjusted change in platelet aggregation following mental stress

*

*

*

*

*

Contact

*

*

Robert W. Harrison, MD

Duke Clinical Research Institute

Durham, NC 27705

Robert.w.harrison@duke.edu

  • Conclusions

References: 1Jiang, W. et al Responses of mental stress induced myocardial ischemia to escitalopram treatment: Background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trial. Am Heart J. 2012; 163:20-6

2Jiang W, et al. Prevalence and clinical characteristics of mental stress-induced myocardial ischemia in patients with coronary heart disease. J Am CollCardiol. 2013; 61:714-722

  • Mental stress testing resulted in increased platelet aggregation, as measured by the AUC and maximal amplitude, in patients who are susceptible to mental stress induced ischemia
  • Future work should investigate whether or not antiplatelet therapy could be protective against mental stress induced myocardial ischemia in susceptible patients